EUVIMEDEUVIMED entdecken
CrossrefInfokarte

RESULTS OF THE USE OF SPPS-S® (STIMULATION OF POLYMODAL SENSORY PERCEPTION BY SKARZYNSKI) BASED ON 4009 PATIENTS WITH CENTRAL AUDITORY PROCESSING DISORDER

Natalia Czajka, Piotr H. Skarzynski, Aleksandra Chodkiewicz, Henryk Skarzynski

Journal of Hearing Science · 2026-05-08 · 16 (1) · 16-22

DOI: 10.17430/jhs/220047 ↗
AbstractBibliografische Angaben

Abstract

Introduction Central auditory processing disorder (CAPD) significantly impair auditory, cognitive, and communicative functioning. Effective rehabilitation requires comprehensive therapeutic approaches integrating multisensory stimulation and modern telemedicine solutions. This study aimed to present the Skarzynski’s Polymodal Sensory Perception Stimulation (SPPS-S®) method and evaluate its effectiveness based on outcomes from over 4,000 patients with CAPD. Material and methods The analysis included 4009 patients who underwent SPPS-S® therapy and a control group of 30 individuals. Auditory processing abilities were assessed using the Frequency Pattern Test (FPT), Duration Pattern Test (DPT), and Dichotic Digit Test (DDT), before and after approximately 3 months of therapy. Statistical analysis was performed using the Wilcoxon signed-rank test. Results Statistically significant improvements were observed in all assessed auditory processing parameters following SPPS-S® therapy (p < 0.05), in both pediatric and adult populations. No significant changes were found in the control group. Conclusions SPPS-S® is an effective, safe, and versatile therapeutic method for CAPD rehabilitation, suitable for both in-clinic and home-based settings, including telemedicine-supported therapy.

Wissen, das zu Ihrer Arbeit passt.

Vom kostenlosen Einstieg über die persönliche Recherche bis zur vollständigen Research Suite.

Tarife ansehen →

Sind alle Verlagsvolltexte enthalten?

Nein. Bibliografische Nachweise, Abstracts und Volltexte sind unterschiedliche Inhalte. Ob ein Volltext verfügbar ist, hängt von der Quelle, Open Access und Ihren vorhandenen Lizenzen ab. Ein EUVIMED-Tarif ersetzt keine zusätzlichen Verlagsrechte.

Tarife ansehen →